Acquired pseudoxanthoma elasticum presenting after liver transplantation - 10/08/11
, Ludovic Martin, MD, PhD b, Nicolas Chassaing, MD, PhD c, Timothy W. Hefferon, PhD d, Didier Bessis, MD e, Olivier Vanakker, MD, PhD f, Sharon F. Terry, MA g
Reprint requests: Lionel Bercovitch, MD, Department of Dermatology, Rhode Island Hospital, 593 Eddy St, Providence, RI 02903.Abstract |
Background |
Pseudoxanthoma elasticum (PXE) is thought to be a metabolic disorder resulting from mutations in the gene encoding the cellular transporter, ABCC6, which is primarily expressed in liver and kidney. We encountered 3 patients who developed clinical and histopathological evidence of PXE after liver transplantation, suggesting that PXE could have been acquired from the transplanted organ.
Objective |
We sought to delineate the clinical features and screen each patient and samples of donor liver for mutations in the ABCC6 gene.
Methods |
Each patient underwent full clinical examination, skin biopsy, and ophthalmologic examination, and whole genome sequencing using standard techniques. Fixed samples of donor liver tissue were available for mutation analysis in two patients and of donor kidney tissue in one.
Results |
All 3 patients had unequivocal clinical and histopathologic evidence of PXE. No patient (or family member available for screening) had evidence of mutations in ABCC6. Neither liver specimen nor the single available kidney specimen showed evidence of mutations in ABCC6.
Limitations |
Liver tissue was not available from one patient and DNA was of poor quality in another, resulting in limited screening. Genetic testing does not detect ABCC6 mutations in 10% of patients with confirmed PXE.
Conclusion |
Although we were unable to demonstrate ABCC6 mutations in limited screening of fixed donor livers, the absence of any PXE mutations in the affected patients, the timing of onset of PXE, and the known acquisition of other metabolic disorders and coagulopathies from donor livers suggest that PXE was likely acquired via liver transplantation.
Le texte complet de cet article est disponible en PDF.Key words : ABCC6, liver transplantation, pseudoxanthoma elasticum
Plan
| PXE International Inc provided funding for genetic testing related to case 3. DNA sequencing of the liver explant sample in case 3 was performed at the National Human Genome Research Institute. |
|
| Disclosure: PXE International Inc is an assigned co-holder of the US patent for the PXE gene, ABCC-6, from which it derives only a token licensing fee. The authors have no conflicts of interest to declare. |
Vol 64 - N° 5
P. 873-878 - mai 2011 Retour au numéro
Article précédent
- Correlation between insulin-like growth factor binding protein-3 serum level and melanoma progression
- Vincenzo Panasiti, Antimo Naspi, Valeria Devirgiliis, Michela Curzio, Vincenzo Roberti, Gianfranca Curzio, Silvia Gobbi, Stefano Calvieri, Paola Londei
- Markedly elevated serum levels of calcium-binding S100A8/A9 proteins in psoriatic arthritis are due to activated monocytes/macrophages
- Seiko Aochi, Kazuhide Tsuji, Masakiyo Sakaguchi, Namho Huh, Tatsuya Tsuda, Kiyofumi Yamanishi, Mayumi Komine, Keiji Iwatsuki
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?